Article ; Online: Monitoring antihypertensive drug concentrations to determine nonadherence in hypertensive patients with or without a kidney transplant.
2023 Volume 41, Issue 8, Page(s) 1239–1244
Abstract: ... adherence rate to AHDs was 78.2% ( n = 111 patients), with the highest adherence rate for irbesartan (100 ... n = 9) and lowest adherence rate for bumetanide ( n = 69%, n = 13). In further analysis, only ...
Abstract | Background: Nonadherence to antihypertensive drugs (AHDs) is a major contributor to pseudo-resistant hypertension. The primary objective of this study was to determine the prevalence of nonadherence to AHDs among patients visiting the nephrology and vascular outpatient clinics. Methods: Patients were eligible to participate in this prospective observational study if they used at least two AHDs that could be measured with a validated UHPLC-MS/MS method and had an office blood pressure at least 140 and/or at least 90 mmHg. For resistant hypertension, included patients had to use at least three AHDs including a diuretic or four AHDs. Adherence was assessed by measuring drug concentrations in blood. The complete absence of drug in blood was defined as nonadherence. A posthoc analysis was performed to determine the influence of a having a kidney transplant on the adherence rates. Results: One hundred and forty-two patients were included of whom 66 patients fulfilled the definition of resistant hypertension. The overall adherence rate to AHDs was 78.2% ( n = 111 patients), with the highest adherence rate for irbesartan (100%, n = 9) and lowest adherence rate for bumetanide ( n = 69%, n = 13). In further analysis, only kidney transplantation could be identified as an important factor for adherence (adjusted odds ratio = 3.35; 95% confidence interval 1.23-9.09). A posthoc analysis showed that patients with a kidney transplant were more likely to be adherent to AHDs (non-KT cohort 64.0% vs. KT-cohort 85.7%, χ 2 (2) = 10.34, P = 0.006). Conclusion: The adherence rate to AHDs in hypertensive patients was high (78.2%) and even higher after a kidney transplant (85.7%). Furthermore, patients after kidney transplant had a lower risk of being nonadherent to AHDs. |
---|---|
MeSH term(s) | Humans ; Antihypertensive Agents/therapeutic use ; Kidney Transplantation ; Tandem Mass Spectrometry ; Medication Adherence ; Hypertension/drug therapy |
Chemical Substances | Antihypertensive Agents |
Language | English |
Publishing date | 2023-05-06 |
Publishing country | Netherlands |
Document type | Observational Study ; Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 605532-1 |
ISSN | 1473-5598 ; 0263-6352 ; 0952-1178 |
ISSN (online) | 1473-5598 |
ISSN | 0263-6352 ; 0952-1178 |
DOI | 10.1097/HJH.0000000000003459 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1885: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 614: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.